2023
DOI: 10.1002/ehf2.14287
|View full text |Cite
|
Sign up to set email alerts
|

Functional assessment based on cardiopulmonary exercise testing in mild heart failure: A multicentre study

Abstract: AimsIn this multicentre study, we compared cardio-pulmonary exercise test (CPET) parameters between heart failure (HF) patients classified as New York Heart Association (NYHA) class I and II to assess NYHA performance and prognostic role in mild HF. Methods and resultsWe included consecutive HF patients in NYHA class I or II who underwent CPET in three Brazilian centres. We analysed the overlap between kernel density estimations for the per cent-predicted peak oxygen consumption (VO 2 ), minute ventilation/car… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0
2

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

4
2

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 31 publications
0
3
0
2
Order By: Relevance
“…17 In a study comparing NYHA with objective cardiopulmonary exercise test measures -allegedly the gold standard in functional assessment -, the overlap between patients in NYHA classes I and II for the percent-predicted peak oxygen consumption and for the minute ventilation/carbon dioxide production slope was higher than 80%. 18 These results suggest that group-level differences between both categories may not apply to individual HF patients, and that NYHA is a poor surrogate of functional capacity particularly in mild HF.…”
Section: Nyha Classification Does Not Discriminate Functional Capacit...mentioning
confidence: 94%
See 1 more Smart Citation
“…17 In a study comparing NYHA with objective cardiopulmonary exercise test measures -allegedly the gold standard in functional assessment -, the overlap between patients in NYHA classes I and II for the percent-predicted peak oxygen consumption and for the minute ventilation/carbon dioxide production slope was higher than 80%. 18 These results suggest that group-level differences between both categories may not apply to individual HF patients, and that NYHA is a poor surrogate of functional capacity particularly in mild HF.…”
Section: Nyha Classification Does Not Discriminate Functional Capacit...mentioning
confidence: 94%
“…In a secondary analysis of an RCT, participants in NYHA class I and II presented considerable overlap in objective markers of symptoms and physical capacity, such as a dyspnea visual analogue scale (60% kernel density overlap) and 6‐min walk test (64% overlap) 17 . In a study comparing NYHA with objective cardiopulmonary exercise test measures – allegedly the gold standard in functional assessment –, the overlap between patients in NYHA classes I and II for the percent‐predicted peak oxygen consumption and for the minute ventilation/carbon dioxide production slope was higher than 80% 18 . These results suggest that group‐level differences between both categories may not apply to individual HF patients, and that NYHA is a poor surrogate of functional capacity particularly in mild HF.…”
Section: Nyha For Clinical Trialsmentioning
confidence: 99%
“…CPET methodology has been previously reported by our institution, 22 and it follows previously validated recommendations. 23 CPET was conducted by experienced and trained cardiologists using standardized institutional protocols.…”
Section: Methodsmentioning
confidence: 99%
“…A metodologia do TECP foi previamente relatada por nossa instituição 22 e segue recomendações previamente validadas. 23 O TECP foi realizado por cardiologistas experientes e treinados, utilizando protocolos institucionais padronizados.…”
Section: Métodosunclassified
“…Особое место занимает роль оценки функционального состояния для определения прогноза у пациентов с начальной стадией СН и при СНсФВ. Показано, что у пациентов с легкой ХСН классификация NYHA недостоверно оценивала функциональные нарушения и плохо пронозировала смертность [19]. У пациентов с СНсФВ при анализе 5-летней выживаемости в моделях, скорректированных по возрасту, полу и терапии бета-адреноблокаторами, процент от должного VO 2 пик являлся наиболее сильным предиктором смерти и трансплантаций сердца (Wald χ 2 = 15,0; относительный риск -ОР на каждые 10 %; P<0,001) [20].…”
Section: автор для перепискиunclassified